Evidence of miR-206 as a tumor growth suppressor has been reported in several cancers: miR-206 was first found to be downregulated in ERalpha-positive human breast cancer tissues and introduction of miR-206 into estrogen-dependent MCF-7 breast cancer cells inhibits cell growth in a dose- and time-dependent manner [25]. Here, ESR1 is linked to breast cancer.